9 Meters Biopharma, Inc. (NMTR) Social Stream
9 Meters Biopharma Inc (NMTR) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering 9 Meters Biopharma Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 121 days, NMTR's average price target has gone down $0.
Over the past 43 weeks, NMTR's average upside potential has been 375.44%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NMTR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 151 days, NMTR's average broker recommendation rating improved by 0.67.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, 9 Meters Biopharma Inc's average analyst price target is greater than 9.04% of them.
- NMTR has a greater upside potential (average analyst target price relative to current price) than 390.87% of all US stocks.
- In the context of stocks in the small market cap category, 9 Meters Biopharma Inc's number of analysts covering the stock is higher than 314.99% of them.
- NMTR has a lower variance in analysts' estimates than -208.69% of stocks in the small market cap category.
Is NMTR a Buy, Hold or Sell? See the POWR Ratings now!